Dana Investment Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.51M | Buy |
24,073
+12,760
| +113% | +$1.33M | 0.08% | 251 |
|
|
2025
Q1 | $1.32M | Sell |
11,313
-5,081
| -31% | -$593K | 0.05% | 341 |
|
|
2024
Q4 | $1.39M | Sell |
16,394
-1,183
| -7% | -$100K | 0.05% | 347 |
|
|
2024
Q3 | $1.58M | Sell |
17,577
-2,147
| -11% | -$193K | 0.05% | 325 |
|
|
2024
Q2 | $1.59M | Buy |
19,724
+697
| +4% | +$56.1K | 0.05% | 324 |
|
|
2024
Q1 | $1.52M | Buy |
19,027
+5,386
| +39% | +$430K | 0.05% | 330 |
|
|
2023
Q4 | $1.09M | Sell |
13,641
-507
| -4% | -$40.4K | 0.05% | 242 |
|
|
2023
Q3 | $989K | Sell |
14,148
-3,468
| -20% | -$242K | 0.05% | 232 |
|
|
2023
Q2 | $1.27M | Sell |
17,616
-1,230
| -7% | -$88.4K | 0.06% | 219 |
|
|
2023
Q1 | $1.16M | Sell |
18,846
-80
| -0.4% | -$4.93K | 0.06% | 217 |
|
|
2022
Q4 | $1.46M | Buy |
18,926
+4,061
| +27% | +$313K | 0.08% | 181 |
|
|
2022
Q3 | $663K | Sell |
14,865
-2,609
| -15% | -$116K | 0.04% | 269 |
|
|
2022
Q2 | $669K | Buy |
17,474
+1,468
| +9% | +$56.2K | 0.03% | 279 |
|
|
2022
Q1 | $662K | Sell |
16,006
-3,613
| -18% | -$149K | 0.03% | 248 |
|
|
2021
Q4 | $741K | Sell |
19,619
-10,756
| -35% | -$406K | 0.03% | 236 |
|
|
2021
Q3 | $1M | Buy |
30,375
+10,527
| +53% | +$347K | 0.05% | 204 |
|
|
2021
Q2 | $1.34M | Buy |
19,848
+1,506
| +8% | +$102K | 0.06% | 194 |
|
|
2021
Q1 | $1.04M | Buy |
+18,342
| New | +$1.04M | 0.05% | 209 |
|